Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
- Conditions
- Breast Cancer
- Interventions
- Radiation: Adjuvant Radiotherapy
- Registration Number
- NCT00003404
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
PURPOSE: This phase II trial studied how well radiation therapy works after surgery in treating women with phyllodes tumor of the breast.
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy following surgery may be effective in treating patients with phyllodes tumor of the breast.
- Detailed Description
OBJECTIVES:
* Determine the local recurrence rate in women with phyllodes tumors of the breast previously treated with local excision with negative margins and are now treated with adjuvant radiotherapy.
* Determine the survival rate in patients treated with this regimen.
METHODS: Within 12 weeks after prior local excision or breast reexcision, patients underwent adjuvant radiotherapy 5 days a week for a total of 28 treatments. Patients were then followed every 6 months for 10 years.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 46
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Adjuvant Radiotherapy Adjuvant Radiotherapy Adjuvant radiation was started within 12 weeks of local excision or breast re-excision.
- Primary Outcome Measures
Name Time Method Local Recurrence Rate 36 months after initial excision Local recurrence rate of phyllodes tumors
- Secondary Outcome Measures
Name Time Method Survival Rate Approximately 5 years Survival will be tracked for 10 years after initial resection of first participant treated.
Trial Locations
- Locations (1)
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States